SNO 2024

November 21-24, 2024
Houston, TX, USA

Society for Neuro-Oncology (SNO) 2024 Annual Meeting

Explore more Neuro-Oncology congress materials

Results(2)

Neuro-Oncology

Allosteric mitochondrial ClpP agonist ONC206 alters stress response, metabolic and epigenetic profiles to elicit anti-cancer efficacy in high-grade gliomas

Author(s): Varun V. Prabhu, Cristina Maranto, Andrew Lee et al.

Response by RANO2.0 criteria in ONC201 (dordaviprone)-treated patients with recurrent H3 K27M-mutant diffuse midline glioma

Author(s): Timothy Cloughesy, MD, Joshua E. Allen, PhD, Isabel Arrillaga-Romany, MD, PhD et al.

Disclaimer

This AI model is continuing to learn and its responses are based on learned data patterns. It should not replace professional judgment. Please verify the information before use, and feedback is welcome to improve its accuracy.

Please do not include personal or confidential information in your searches. For information on how to report an adverse event or product complaint for a Jazz product, please visit: https://www.jazzpharma.com/medicines/drug-safety/.